Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34+ cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine.
about
Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndromeRibosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implicationsMinority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
P2860
Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34+ cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@en
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@nl
type
label
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@en
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@nl
prefLabel
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@en
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@nl
P2093
P2860
P1433
P1476
Over-expression of RPL23 in my ...... HG chemotherapy or decitabine.
@en
P2093
Chunkang Chang
Lingyun Wu
Zheng Zhang
P2860
P304
P356
10.1007/S00277-012-1486-2
P577
2012-05-13T00:00:00Z